Deborah Birx
Chief Executive Officer bij ARMATA PHARMACEUTICALS, INC.
Vermogen: 2 M $ op 31-03-2024
Actieve functies van Deborah Birx
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Director/Board Member | 11-07-2023 | - |
| Chief Executive Officer | 11-07-2023 | - | |
Nanolive SA
 Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Director/Board Member | - | - |
Loopbaan van Deborah Birx
Eerdere bekende functies van Deborah Birx
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INNOVIVA, INC. | Director/Board Member | 09-03-2021 | 10-07-2023 |
| Independent Dir/Board Member | 09-03-2021 | 10-07-2023 |
Opleiding van Deborah Birx
| Houghton College | Undergraduate Degree |
| Pennsylvania State University College of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Zwitserland | 2 |
Operationeel
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| ARMATA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Nanolive SA
Nanolive SA Medical SpecialtiesHealth Technology Nanolive SA develops revolutionary tomographic microscope to look instantly inside living cells in 3D. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, drug monitoring, and in vitro fertilization. The company was founded in November 2013 by Yann Cotte, Sebastien Equis, and Andreas Kern, Fatih Toy, Christian Depeursinge and is headquartered in Ecublens, Switzerland. | Health Technology |
- Beurs
- Insiders
- Deborah Birx
- Ervaring
